Piroxicam(CP-16171)吡罗昔康 非甾体抗炎药/COX抑制剂|CAS 36322-90-4（53662ES）

Piroxicam (CP-16171, CP16171)，又称吡罗昔康，是一种非甾体抗炎药，具有镇痛、抗炎及解热作用，也是COX的抑制剂，临床上用于治疗风湿性及类风湿性关节炎等疾病。Piroxicam通过抑制COX活性阻碍炎症的介质前列腺素的生物合成进而发挥药理作用。

参考文献

1.Kato M, et al. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes. J Pharm Pharmacol. 2001 Dec;53(12):1679-85.

2.Silva J, et al. Synergistic Effect of Carboplatin and Piroxicam on Two Bladder Cancer Cell Lines. Anticancer Res. 2017 Apr;37(4):1737-1745.

3.Mohammed SI, et al. Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Cancer Res. 2002 Jan 15;62(2):356-8.

冰袋运输。粉末直接保存于-20℃，有效期3年。建议分装后-20℃干燥保存，避免反复冻融。